Tirzepatide is a dual agonist that engages both the GIP and GLP-1 receptor pathways, whereas compounds like semaglutide act on GLP-1 alone
High-polyphenol EVOO is a nutritional tool that may support metabolic health through multiple mechanisms, including modest support of natural GLP-1 secretion
En resumen, a partir de este grupo de pptidos se han desarrollado frmacos con efecto antihiperglucemiante que intentan obviar la rpida degradacin de las incretinas una vez secretadas y se han desarrollado otras estrategias teraputicas para evitar este deterioro de la respuesta a las incretinas: los arGLP-1, resistentes a la degradacin por DPP-4 y los iDPP-4
Here are some of them, but the use of these medications is still being studied, and we need more longitudinal (long-term) data
It works by increasing brain active compounds or neurotransmitters, including norepinephrine, that affect hunger signals in the brain